BCYC
Price
$8.10
Change
+$0.25 (+3.18%)
Updated
Apr 2, 02:43 PM (EDT)
Capitalization
543.24M
29 days until earnings call
RPTX
Price
$1.02
Change
+$0.03 (+3.03%)
Updated
Apr 1 closing price
Capitalization
43.36M
41 days until earnings call
Ad is loading...

BCYC vs RPTX

Header iconBCYC vs RPTX Comparison
Open Charts BCYC vs RPTXBanner chart's image
Bicycle Therapeutics
Price$8.10
Change+$0.25 (+3.18%)
Volume$100
Capitalization543.24M
Repare Therapeutics
Price$1.02
Change+$0.03 (+3.03%)
Volume$269.27K
Capitalization43.36M
BCYC vs RPTX Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RPTX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and RPTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (BCYC: $7.85 vs. RPTX: $1.02)
Brand notoriety: BCYC and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 134% vs. RPTX: 122%
Market capitalization -- BCYC: $543.24M vs. RPTX: $43.36M
BCYC [@Biotechnology] is valued at $543.24M. RPTX’s [@Biotechnology] market capitalization is $43.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • RPTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than RPTX.

Price Growth

BCYC (@Biotechnology) experienced а -11.30% price change this week, while RPTX (@Biotechnology) price change was -0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.99%. For the same industry, the average monthly price growth was -7.23%, and the average quarterly price growth was -11.71%.

Reported Earning Dates

BCYC is expected to report earnings on May 01, 2025.

RPTX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-4.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($543M) has a higher market cap than RPTX($43.4M). RPTX YTD gains are higher at: -22.137 vs. BCYC (-43.929). RPTX has higher annual earnings (EBITDA): -90.22M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. RPTX (153M). RPTX has less debt than BCYC: RPTX (1.93M) vs BCYC (9.49M). RPTX has higher revenues than BCYC: RPTX (53.5M) vs BCYC (35.3M).
BCYCRPTXBCYC / RPTX
Capitalization543M43.4M1,251%
EBITDA-164.89M-90.22M183%
Gain YTD-43.929-22.137198%
P/E RatioN/AN/A-
Revenue35.3M53.5M66%
Total Cash880M153M575%
Total Debt9.49M1.93M491%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCRPTX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNIT5.220.18
+3.57%
Uniti Group
FCFS121.050.73
+0.61%
FirstCash Holdings
ORLY1431.80-0.78
-0.05%
O'Reilly Automotive
EBTC38.89-0.04
-0.10%
Enterprise Bancorp
IPSC0.45-0.02
-5.08%
Century Therapeutics

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+3.46%
INO - RPTX
57%
Loosely correlated
-7.98%
BCYC - RPTX
48%
Loosely correlated
-7.54%
ALNY - RPTX
38%
Loosely correlated
-5.28%
AXON - RPTX
37%
Loosely correlated
+2.90%
GSGTF - RPTX
34%
Loosely correlated
N/A
More